FREMONT, Calif.--(BUSINESS WIRE)--Genitope Corporation (Nasdaq: GTOP) today announced that the underwriter of its follow-on public offering of 5,500,000 shares has exercised its over-allotment option as to 510,279 additional shares of common stock. Including the over-allotment shares purchased yesterday, the offering totaled 6,010,279 shares of common stock at the public offering price of $3.85 per share, resulting in net proceeds to Genitope Corporation of approximately $21.6 million. All of the shares in the offering were offered and sold by Genitope Corporation under its effective shelf registration statement.
